| Identifier |
20050216_nanos_controversies_04.pdf |
| Title |
Myasthenia Gravis: Recent Developments |
| Creator |
Henry J. Kaminski, MD |
| Affiliation |
Cleveland, OH |
| Subject |
Multiple Sclerosis; Optic Neuritis; Clinically Isolated Syndrome; Immunomodulatory Agents; Methylprednisolone |
| Description |
To: 1. Describe the potential mechanisms for preferential involvement of ocular muscles by myasthenia gravis; 2. Discuss risks and benefits of corticosteroid use for treatment of ocular myasthenia; 3. Appropriately use edrophonium, serum autoantibody and electrodiagnostic evaluation for confirmation of diagnosis of myasthenia gravis. |
| Date |
2005-02-16 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2005 North American Neuro-Ophthalmology Society Annual Meeting |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6cc464h |
| Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
| Setname |
ehsl_novel_nam |
| ID |
181280 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6cc464h |
